Walden Group Healthcare M&A Blog

  • CVS Acquires Signify Health for $8b

    9/23/2022
    CVS Health Corporation is buying Signify Health, a $773.4m provider of home and virtual healthcare services.  The acquisition adds a mobile network of 10,000 credentialed clinicians offering in-home evaluations of Medicare Advantage and Medicaid plan members.  The deal represents a shift in the drugstore chain’s traditional brick and mortar...
    Read More
  • Teleflex Acquires Standard Bariatrics for $170m

    9/1/2022
    Teleflex, a $2.8b producer of single-use devices for diagnostic, critical care and surgical applications, is buying Standard Bariatrics, a developer of a powered stapling technology for bariatric surgery.  Standard Bariatrics has commercialized its stapler platform which enables surgeons to place continuous staples in one firing, minimizing...
    Read More
  • Patient Square Capital to Acquire Hanger for $1.2b

    8/10/2022
    Hanger, Inc. (NYSE: HNGR), a $1.14b provider of orthotic and prosthetic (O&P) patient care services and devices, announced that it will be taken private by Patient Square Capital, a private investment firm.  Hanger operates 875 clinic locations nationwide and distributes branded and private label O&P devices. Deal value - $1.25b on sales...
    Read More
  • BD (Becton, Dickinson and Company) Completes $1.5b Acquisition of Parata Systems

    7/18/2022
    Parata Systems adds a portfolio of pharmacy automation solutions that reduce costs, enhance patient safety and improve patient experience for retail, hospital and long-term care pharmacies.  The pharmacy automation market is worth an estimated $600 million and is expected to grow approximately 10% annually to $1.5 billion in the U.S. alone over...
    Read More
  • OrthoPediatrics to Acquire Pega Medical

    6/23/2022
    OrthoPediatrics, a $98m producer of implants and devices that treat orthopedic conditions in children, is acquiring Canada-based Pega Medical, a developer of implant systems that treat bony deformities in children with osteogenesis imperfecta (brittle bone disease), for $33m.  The acquisition adds to OrthoPediatrics’ range of technologies...
    Read More